A Agilent Technologies Inc.

Agilent Presents Solutions Innovation Research Awards to Cornell and Indiana University Researchers

(NYSE: A) today announced two Solutions Innovation Research Awards (SIRA) presented to Professors and . These separate awards recognize their outstanding contributions to advanced materials research.

Electrocatalysis plays a pivotal role in advancing clean energy systems. Enhancing the efficiency of chemical reactions at electrode surfaces can accelerate the transition to sustainable energy sources. High-entropy nanoparticles—materials that incorporate many different types of atoms into one lattice—offer a fresh perspective in electrocatalysis. Their complexity, stability, and tunability make them promising candidates for efficient and sustainable energy conversion. These materials can be readily incorporated into fuel cells and other energy systems.

Professor Richard Robinson specializes in colloidal nanoparticle synthesis and applies nanosynthetic design concepts to control nanomaterials’ composition, shape, size, and surface to tailor their properties. As part of his award, Professor Robinson will receive a one-year loan of an Agilent Cary 630 FTIR system, which will aid his groups’ efforts to characterize the structures of novel high-entropy nanomaterials.

Professor Xingchen Ye is an expert in the synthesis and analysis of nanomaterials for fuel-cell and semiconductor applications. He will seek to establish composition-dependent optical benchmarks for various nanoparticle (NP) compositions. As part of his award, Professor Ye will receive a one-year loan of an Agilent Cary 5000 UV-Vis-NIR spectrophotometer, which will be used to perform extinction spectroscopy analysis of NP samples.

“By using colloidal nanosynthetic chemistry, we’re able to tinker with the building blocks of materials at the atomic and molecular scale. High entropy materials expand our toolkit to alter nanoparticle properties beyond the conventional knobs we use. By scrambling atoms randomly, we could unlock countless unknown arrangements, leading to unknown properties. This is an exciting new frontier and opens up new possibilities for efficient fuel cells, thermoelectrics, and other energy applications,” said Professor Robinson. “We’re really very grateful for this award from Agilent; it’s going to be a huge boost to our research.”

“We appreciate this recognition from Agilent,” said Professor Ye. “Our objective is to reveal emerging and distinctive properties in nanomaterials, enhancing their suitability for fuel-cell and semiconductor applications. This award will significantly support and propel our research forward.”

Geoff Winkett, vice president and general manager of Agilent's Molecular Spectroscopy Division, spoke about the importance of these awards. “The research being carried out by Professor Robinson and Professor Ye has the potential to promote more sustainable energy storage, which will be essential for driving technological advancements and reshaping industries. Agilent proudly supports this transformative journey towards discovering advanced materials and battery technologies that will lay the foundation for a sustainable and resilient future.”

A leading provider of spectroscopy solutions for materials analysis, Agilent is committed to promoting university research through a portfolio of products and technical expertise that enable researchers to drive their work forward. The Solutions Innovation Research Award (SIRA) program, under the guidance of Dr. Chong Wing Yung, Associate Director of University Relations and External Research at Agilent, is designed to stimulate the most innovative and impactful use of Agilent products to help solve pressing scientific problems in academia. For more information about the Agilent Solutions Innovation Research Award (SIRA) visit .

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the . Follow Agilent on and .

EN
16/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approva...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ , a recently approved CAR T therapy. Agilent's advanced cell analysis instrumentation, specifically the technology, was applied in developing and validating AUCATZYL. The xCELLigence RTCA technology supported the development and implementation of the potency assay. By providing precise and reliable cell analysis solutions, Agilent assisted Autolus in achieving the high standards required for FDA approval. Dr. Xiaobo Wang, Vice President and General Manager of the Cell Functio...

 PRESS RELEASE

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE NEXT-GENERATION DIGITAL PATHOLOGY SOLUTIONS AT USCAP 2025 (NYSE: A) is excited to announce its participation at the upcoming , which will be held March 22-27, 2025, in Boston. At the conference, Agilent will highlight innovative digital pathology solutions designed to enhance diagnostic accuracy and efficiency. In pathology, Agilent offers comprehensive tissue diagnostic solutions for analyzi...

 PRESS RELEASE

Agilent Research Catalyst Award Presented to Columbia University for P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced that has received an Agilent Research Catalyst (ARC) Award on behalf of , an internationally recognized researcher and physician-scientist specializing in bone marrow transplant (BMT) and cancer cellular immunotherapy. Dr. Muranski is the Director of Cellular Immunotherapy Laboratory at Columbia University Irving Medical Center. He is also an Assistant Professor of Medicine at Columbia University Medical Center, a principal investigator at the Columbia Center for Translational Immunology (CCTI), and a member of the Herbert Irv...

 PRESS RELEASE

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Com...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced its kit has received two new companion diagnostic indications approvals under EU IVDR1, expanding the eligibility of treatment to early-stage non-small cell lung cancer (NSCLC) and previously untreated advanced melanoma patients. These two new indications bring the total indications launched in Europe for PD-L1 IHC 28-8 pharmDx to nine. PD-L1 IHC 28-8 pharmDx is approved for exclusive use with the advanced staining solution. Lung cancer and malignant melanoma are major healthcare concerns worldwide, with lung cancer accountin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch